** Shares of dialysis products maker Rockwell Medical Inc
RMTI.O rise 9.4% to $3.26 premarket
** Co raises 2023 net sales outlook to between $82.0 mln and
$86.0 mln from between $78.0 mln and $82.0 mln
** Analysts were expecting net sales of $86.1 mln -
Refinitiv
** RMTI sees Q3 net sales to be between $21.0 mln and $23.0
mln vs. analysts' estimates of $23.67 mln -Refinitiv
** RMTI also raises 2023 gross profit outlook to between
$8.0 mln and $10.0 mln from between $7.0 mln and $9.0 mln
previously
** Up to last close, stock nearly tripled so far this year
(Reporting by Mariam Sunny in Bengaluru)
((Mariam.ESunny@thomsonreuters.com;))